Guidant (GDT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guidant (GDT)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Lighthouse who wrote (209)	10/2/2002 11:58:49 AM
From: Ausdauer	of 235

"GDT is making a big investment in Cook in order to try to level the playing field. At the current stock price of GDT a $3 billion dollar investment translates to about 80 million new GDT shares, a greater than 25% dilution in outstanding shares. That is a big price to pay for technology that is second to market. If the deal falls through and GDT has no drug-eluting stents to compete with JNJ it is easy to predict that it will lose substantial market share in this book of business, and quite rapidly." Message 17949433 I think it was a no-win situation for GDT and today's market action reflects that. Boston Scientific spent millions on research in good faith expecting the previously negotiated licenses to come through. GDT's tactics were executed, IMHO, in desperation. Message 17954318 Aus (GDT intraday low $24.75)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next